Energy infrastructure company Kinder Morgan (NYSE: KMI) reported an increase in first-quarter revenues, helped mainly by strong contributions from the natural gas business segment. While the top-line missed, earnings came in line with Wall Street estimates.
Adjusted earnings rose to 25 cents per share from 22 cents per share in the year-over-period and matched estimates. Net profit, on a reported basis, was $556 million or 24 cents per share during the three-month period, compared to $485 million or 22 cents per share a year earlier.
At $3.43 billion, revenues were up 0.3% compared to the year-ago quarter. The top line benefitted from a strong performance by the natural gas segment but missed analysts’ forecast.
KMI shares fell 0.2% during aftermarket trading on Wednesday. The stock has gained 24% in the trailing 52 weeks and 25% in the year-to-date period.
CEO Steve Kean said, “Contributions from our Natural Gas Pipelines segment were up substantially compared to the first quarter of 2018. We continued to make progress on two projects critical to the development of resources in the Permian Basin: the Gulf Coast Express and Permian Highway Pipeline projects, as well as our Elba Liquefaction facility.”
READ: LYFT AND SIX OTHER COMPANIES WENT PUBLIC IN MARCH. FULL LIST
Looking ahead, the management reiterated its expectation of distributable cash flow at $5 billion in fiscal 2019 when adjusted EBITDA is anticipated to come in at $7.8 billion. During the fiscal year, a total of $3.1 billion will be invested in growth projects and joint ventures.
The Kinder Morgan board also announced a cash dividend of $0.25 per share for the first quarter payable on May 15, 2019, to common stockholders of record as on April 30, 2019.
Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on